Synthesis, molecular docking, ADMET studies and biological evaluation of fused pyrazolopyridopyrimidine derivatives as antioxidant and antimicrobial agents.

Sci Rep · 2025 · PMC12701012 · PMID 41381722

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Progressive increase in activity with specific core modifications: a clear trend is observed when moving through the synthetic schemes: the initial pyrazolopyridines (1–5) show very low antioxidant activity.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.